SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-042586
Filing Date
2007-02-28
Accepted
2007-02-28 16:07:05
Documents
9
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1580396
2 THIRD AMENDMENT TO THE AMGEN SUPPLEMENTAL RETIREMENT PLAN dex1011.htm EX-10.11 5312
3 EIGHTH AMENDMENT TO CHANGE OF CONTROL SEVERANCE PLAN dex1020.htm EX-10.20 5806
4 THIRD AMENDMENT TO THE NONQUALIFIED DEFERRED COMPENSATION PLAN dex1027.htm EX-10.27 6595
5 SUBSIDIARIES OF THE COMPANY dex21.htm EX-21 1923
6 RULE 13A-14(A) CERTIFICATIONS dex31.htm EX-31 18419
7 SECTION 1350 CERTIFICATIONS dex32.htm EX-32 8304
8 GRAPHIC g49164chart_001.jpg GRAPHIC 55189
9 GRAPHIC g49164g55q56.jpg GRAPHIC 166346
  Complete submission text file 0001193125-07-042586.txt   1933810
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-12477 | Film No.: 07657828
SIC: 2836 Biological Products, (No Diagnostic Substances)